You are here

Vitamin D could be 'key' to multiple sclerosis treatment

Vitamin D could be 'key' to multiple sclerosis treatment
23rd November 2009

Vitamin D could be the way to quell the wider issues associated with multiple sclerosis (MS), according to a recent Australian report.

In a study by Professor Bruce Taylor, a principle research fellow at the Menzies Institute in Hobart, it was concluded that MS attacks can happen seasonally and that the use of vitamin D to replace the natural amount usually given by the sun can help cut down on such instances.

He explained that attacks are more common in spring than in autumn, noting that a ten-nanomole increase in the vitamin can reduce the risk of a relapse by ten per cent.

Professor Taylor added that a doubling of vitamin D intake can cut down on the chance of a relapse by 50 per cent.

Speaking to the Daily Mail, Multiple Sclerosis Resource Centre chief executive Helen Yates said: "It has long been believed that vitamin D has a role to play in the risk of developing MS but this new research opens up the strong possibility that this vitamin could impact on relapse rates."

According to the MS Society, around 100,000 people in the UK have the condition.

Please click here for advice to help you find the right type of care.